SFI
FLNA

Susquehanna Fundamental Investments’s Filana Therapeutics FLNA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,493
Closed -$17.2K – 969
2025
Q1 		$17.2K Hold
11,493
– – ﹤0.01% 1053
2024
Q4 		$27.1K Buy
+11,493
New +$202K ﹤0.01% 1063
2021
Q1 		– Sell
-17,044
Closed -$116K – 1605
2020
Q4 		$116K Buy
17,044
+2,544
+18% +$22.7K ﹤0.01% 1413
2020
Q3 		$167K Hold
14,500
– – 0.01% 1226
2020
Q2 		$45K Buy
+14,500
New +$65.8K ﹤0.01% 943

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna Fundamental Investments's FLNA Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 11,493 shares — an estimated $17.2K sold.

Susquehanna Fundamental Investments first reported a position in FLNA in Q2 2020 and held it in 5 quarters. The position peaked at $167K in Q3 2020. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 11,493 Filana Therapeutics shares in Q2 2025, an estimated $17.2K.
  • Susquehanna Fundamental Investments first reported a position in Filana Therapeutics in Q2 2020 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's Filana Therapeutics position peaked at $167K in Q3 2020.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.